Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Grant/Award of 4,545 RPRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 4,545 | n/a |
| Mar 3, 2026 | Biohaven Ltd. (BHVN) | Grant/Award | 550,000 | n/a |
| Feb 6, 2026 | Veradermics, Inc (MANE) | Conversion | 33,706 | n/a |
| Jan 8, 2026 | Biohaven Ltd. (BHVN) | Exercise/Conversion | 14,250 | n/a |
| Nov 17, 2025 | Biohaven Ltd. (BHVN) | Purchase | 333,333 | $2.50M |
| May 14, 2025 | Royalty Pharma plc (RPRX) | Grant/Award | 7,614 | n/a |
| Apr 21, 2025 | Royalty Pharma plc (RPRX) | Grant/Award | 3,184 | n/a |
| Jan 8, 2025 | Biohaven Ltd. (BHVN) | Exercise/Conversion | 14,250 | n/a |
| Oct 3, 2024 | Biohaven Ltd. (BHVN) | Purchase | 21,052 | $1000.0K |
| May 3, 2024 | Revance Therapeutics, Inc. (RVNC) | Grant/Award | 15,000 | n/a |